APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary & Animal Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary & Animal Vaccines Market Outlook and Growth Opportunities 2026

Report ID 174045880420 December 2025198 pages

Choose your research edition.

Industry ResearchVeterinary & Animal Vaccines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary & Animal Vaccines Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Veterinary & Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary & Animal Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary & Animal Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Veterinary & Animal Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary & Animal Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary & Animal Vaccines market include Zoetis, Tianjin Ringpu, Merck Animal Health, Virbac, Vetoquinol, Phibro Animal Health, Idt Biologika, Hipra and Hester, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary & Animal Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary & Animal Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary & Animal Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary & Animal Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary & Animal Vaccines Segment by Company

Zoetis

Tianjin Ringpu

Merck Animal Health

Virbac

Vetoquinol

Phibro Animal Health

Idt Biologika

Hipra

Hester

Elanco

China Animal Husbandry

Boehringer Ingelheim

Biogenesis Bago

Veterinary & Animal Vaccines Segment by Type

Live Attenuated Vaccines

Toxoid Vaccines

Inactivated Vaccines

Recombinant Vaccines

Other Vaccines

Veterinary & Animal Vaccines Segment by Application

Hospitals and Clinics

Others

Veterinary & Animal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Veterinary & Animal Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary & Animal Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary & Animal Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary & Animal Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary & Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary & Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary & Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary & Animal Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary & Animal Vaccines industry.

Chapter 3: Detailed analysis of Veterinary & Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary & Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary & Animal Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary & Animal Vaccines Industry Trends Table 2. Veterinary & Animal Vaccines Industry Drivers Table 3. Veterinary & Animal Vaccines Industry Opportunities and Challenges Table 4. Veterinary & Animal Vaccines Industry Restraints Table 5. Global Veterinary & Animal Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary & Animal Vaccines Revenue Share by Company (2021-2026) Table 7. Global Veterinary & Animal Vaccines Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Veterinary & Animal Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary & Animal Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Veterinary & Animal Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary & Animal Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary & Animal Vaccines Company, Product Type & Application Table 13. Global Veterinary & Animal Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary & Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Attenuated Vaccines Table 18. Significant Companies of Toxoid Vaccines Table 19. Significant Companies of Inactivated Vaccines Table 20. Significant Companies of Recombinant Vaccines Table 21. Significant Companies of Other Vaccines Table 22. Global Veterinary & Animal Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Veterinary & Animal Vaccines Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Veterinary & Animal Vaccines Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Veterinary & Animal Vaccines Sales Volume Share by Type (2021-2026) Table 26. Global Veterinary & Animal Vaccines Sales Volume Share by Type (2027-2032) Table 27. Global Veterinary & Animal Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Veterinary & Animal Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Veterinary & Animal Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Veterinary & Animal Vaccines Sales Value Share by Type (2021-2026) Table 31. Global Veterinary & Animal Vaccines Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospitals and Clinics Table 33. Significant Companies of Others Table 34. Global Veterinary & Animal Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Veterinary & Animal Vaccines Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Veterinary & Animal Vaccines Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Veterinary & Animal Vaccines Sales Volume Share by Application (2021-2026) Table 38. Global Veterinary & Animal Vaccines Sales Volume Share by Application (2027-2032) Table 39. Global Veterinary & Animal Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Veterinary & Animal Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Veterinary & Animal Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Veterinary & Animal Vaccines Sales Value Share by Application (2021-2026) Table 43. Global Veterinary & Animal Vaccines Sales Value Share by Application (2027-2032) Table 44. Global Veterinary & Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Veterinary & Animal Vaccines Sales by Region (2021-2026) & (K Units) Table 46. Global Veterinary & Animal Vaccines Sales Market Share by Region (2021-2026) Table 47. Global Veterinary & Animal Vaccines Sales by Region (2027-2032) & (K Units) Table 48. Global Veterinary & Animal Vaccines Sales Market Share by Region (2027-2032) Table 49. Global Veterinary & Animal Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Veterinary & Animal Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Veterinary & Animal Vaccines Sales Value Share by Region (2021-2026) Table 52. Global Veterinary & Animal Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Veterinary & Animal Vaccines Sales Value Share by Region (2027-2032) Table 54. Global Veterinary & Animal Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Veterinary & Animal Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Veterinary & Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Veterinary & Animal Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 59. Global Veterinary & Animal Vaccines Sales Market Share by Country (2021-2026) Table 60. Global Veterinary & Animal Vaccines Sales by Country (2027-2032) & (K Units) Table 61. Global Veterinary & Animal Vaccines Sales Market Share by Country (2027-2032) Table 62. Global Veterinary & Animal Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Veterinary & Animal Vaccines Sales Value Market Share by Country (2021-2026) Table 64. Global Veterinary & Animal Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Veterinary & Animal Vaccines Sales Value Market Share by Country (2027-2032) Table 66. Zoetis Company Information Table 67. Zoetis Business Overview Table 68. Zoetis Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Zoetis Veterinary & Animal Vaccines Product Portfolio Table 70. Zoetis Recent Development Table 71. Tianjin Ringpu Company Information Table 72. Tianjin Ringpu Business Overview Table 73. Tianjin Ringpu Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio Table 75. Tianjin Ringpu Recent Development Table 76. Merck Animal Health Company Information Table 77. Merck Animal Health Business Overview Table 78. Merck Animal Health Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck Animal Health Veterinary & Animal Vaccines Product Portfolio Table 80. Merck Animal Health Recent Development Table 81. Virbac Company Information Table 82. Virbac Business Overview Table 83. Virbac Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Virbac Veterinary & Animal Vaccines Product Portfolio Table 85. Virbac Recent Development Table 86. Vetoquinol Company Information Table 87. Vetoquinol Business Overview Table 88. Vetoquinol Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Vetoquinol Veterinary & Animal Vaccines Product Portfolio Table 90. Vetoquinol Recent Development Table 91. Phibro Animal Health Company Information Table 92. Phibro Animal Health Business Overview Table 93. Phibro Animal Health Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio Table 95. Phibro Animal Health Recent Development Table 96. Idt Biologika Company Information Table 97. Idt Biologika Business Overview Table 98. Idt Biologika Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Idt Biologika Veterinary & Animal Vaccines Product Portfolio Table 100. Idt Biologika Recent Development Table 101. Hipra Company Information Table 102. Hipra Business Overview Table 103. Hipra Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hipra Veterinary & Animal Vaccines Product Portfolio Table 105. Hipra Recent Development Table 106. Hester Company Information Table 107. Hester Business Overview Table 108. Hester Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hester Veterinary & Animal Vaccines Product Portfolio Table 110. Hester Recent Development Table 111. Elanco Company Information Table 112. Elanco Business Overview Table 113. Elanco Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Elanco Veterinary & Animal Vaccines Product Portfolio Table 115. Elanco Recent Development Table 116. China Animal Husbandry Company Information Table 117. China Animal Husbandry Business Overview Table 118. China Animal Husbandry Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio Table 120. China Animal Husbandry Recent Development Table 121. Boehringer Ingelheim Company Information Table 122. Boehringer Ingelheim Business Overview Table 123. Boehringer Ingelheim Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio Table 125. Boehringer Ingelheim Recent Development Table 126. Biogenesis Bago Company Information Table 127. Biogenesis Bago Business Overview Table 128. Biogenesis Bago Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio Table 130. Biogenesis Bago Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Veterinary & Animal Vaccines Distributors List Table 134. Veterinary & Animal Vaccines Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Veterinary & Animal Vaccines Product Image Figure 2. Global Veterinary & Animal Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary & Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary & Animal Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Veterinary & Animal Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Veterinary & Animal Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Attenuated Vaccines Image Figure 10. Toxoid Vaccines Image Figure 11. Inactivated Vaccines Image Figure 12. Recombinant Vaccines Image Figure 13. Other Vaccines Image Figure 14. Global Veterinary & Animal Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Veterinary & Animal Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary & Animal Vaccines Sales Volume Share by Type (2021-2032) Figure 17. Global Veterinary & Animal Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Veterinary & Animal Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Veterinary & Animal Vaccines Sales Value Share by Type (2021-2032) Figure 20. Hospitals and Clinics Image Figure 21. Others Image Figure 22. Global Veterinary & Animal Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Veterinary & Animal Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary & Animal Vaccines Sales Volume Share by Application (2021-2032) Figure 25. Global Veterinary & Animal Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Veterinary & Animal Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Veterinary & Animal Vaccines Sales Value Share by Application (2021-2032) Figure 28. Global Veterinary & Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Veterinary & Animal Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Veterinary & Animal Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Veterinary & Animal Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Veterinary & Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. North America Veterinary & Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Veterinary & Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Veterinary & Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Veterinary & Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Veterinary & Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Veterinary & Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. South America Veterinary & Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Veterinary & Animal Vaccines Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Veterinary & Animal Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Veterinary & Animal Vaccines Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Veterinary & Animal Vaccines Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Other Vaccines
Applications
  • Hospitals and Clinics
  • Others
Companies covered
  • Zoetis
  • Tianjin Ringpu
  • Merck Animal Health
  • Virbac
  • Vetoquinol
  • Phibro Animal Health
  • Idt Biologika
  • Hipra
  • Hester
  • Elanco
  • China Animal Husbandry
  • Boehringer Ingelheim
  • Biogenesis Bago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary & Animal Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary & Animal Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary & Animal Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary & Animal Vaccines Market Dynamics
  1. 2.1 Veterinary & Animal Vaccines Industry Trends
  2. 2.2 Veterinary & Animal Vaccines Industry Drivers
  3. 2.3 Veterinary & Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Veterinary & Animal Vaccines Industry Restraints
3 Veterinary & Animal Vaccines Market by Company
  1. 3.1 Global Veterinary & Animal Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary & Animal Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary & Animal Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary & Animal Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary & Animal Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Veterinary & Animal Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary & Animal Vaccines Company Product Type and Application
  8. 3.8 Global Veterinary & Animal Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary & Animal Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary & Animal Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary & Animal Vaccines Market by Type
  1. 4.1 Veterinary & Animal Vaccines Type Introduction
  2. 4.1.1 Live Attenuated Vaccines
  3. 4.1.2 Toxoid Vaccines
  4. 4.1.3 Inactivated Vaccines
  5. 4.1.4 Recombinant Vaccines
  6. 4.1.5 Other Vaccines
  7. 4.2 Global Veterinary & Animal Vaccines Sales Volume by Type
  8. 4.2.1 Global Veterinary & Animal Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Veterinary & Animal Vaccines Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Veterinary & Animal Vaccines Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Veterinary & Animal Vaccines Sales Value by Type
  12. 4.3.1 Global Veterinary & Animal Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Veterinary & Animal Vaccines Sales Value by Type (2021-2032)
  14. 4.3.3 Global Veterinary & Animal Vaccines Sales Value Share by Type (2021-2032)
5 Veterinary & Animal Vaccines Market by Application
  1. 5.1 Veterinary & Animal Vaccines Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Others
  4. 5.2 Global Veterinary & Animal Vaccines Sales Volume by Application
  5. 5.2.1 Global Veterinary & Animal Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary & Animal Vaccines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Veterinary & Animal Vaccines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Veterinary & Animal Vaccines Sales Value by Application
  9. 5.3.1 Global Veterinary & Animal Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Veterinary & Animal Vaccines Sales Value by Application (2021-2032)
  11. 5.3.3 Global Veterinary & Animal Vaccines Sales Value Share by Application (2021-2032)
6 Veterinary & Animal Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Veterinary & Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary & Animal Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary & Animal Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary & Animal Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Veterinary & Animal Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary & Animal Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary & Animal Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary & Animal Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary & Animal Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary & Animal Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary & Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary & Animal Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary & Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary & Animal Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary & Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary & Animal Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary & Animal Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary & Animal Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary & Animal Vaccines Sales Value Share by Country, 2025 VS 2032
7 Veterinary & Animal Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary & Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary & Animal Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary & Animal Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary & Animal Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary & Animal Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Veterinary & Animal Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary & Animal Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary & Animal Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary & Animal Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary & Animal Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary & Animal Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary & Animal Vaccines Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Tianjin Ringpu
  8. 8.2.1 Tianjin Ringpu Company Information
  9. 8.2.2 Tianjin Ringpu Business Overview
  10. 8.2.3 Tianjin Ringpu Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio
  12. 8.2.5 Tianjin Ringpu Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Veterinary & Animal Vaccines Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Veterinary & Animal Vaccines Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vetoquinol
  26. 8.5.1 Vetoquinol Company Information
  27. 8.5.2 Vetoquinol Business Overview
  28. 8.5.3 Vetoquinol Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol Veterinary & Animal Vaccines Product Portfolio
  30. 8.5.5 Vetoquinol Recent Developments
  31. 8.6 Phibro Animal Health
  32. 8.6.1 Phibro Animal Health Company Information
  33. 8.6.2 Phibro Animal Health Business Overview
  34. 8.6.3 Phibro Animal Health Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio
  36. 8.6.5 Phibro Animal Health Recent Developments
  37. 8.7 Idt Biologika
  38. 8.7.1 Idt Biologika Company Information
  39. 8.7.2 Idt Biologika Business Overview
  40. 8.7.3 Idt Biologika Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Idt Biologika Veterinary & Animal Vaccines Product Portfolio
  42. 8.7.5 Idt Biologika Recent Developments
  43. 8.8 Hipra
  44. 8.8.1 Hipra Company Information
  45. 8.8.2 Hipra Business Overview
  46. 8.8.3 Hipra Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hipra Veterinary & Animal Vaccines Product Portfolio
  48. 8.8.5 Hipra Recent Developments
  49. 8.9 Hester
  50. 8.9.1 Hester Company Information
  51. 8.9.2 Hester Business Overview
  52. 8.9.3 Hester Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hester Veterinary & Animal Vaccines Product Portfolio
  54. 8.9.5 Hester Recent Developments
  55. 8.10 Elanco
  56. 8.10.1 Elanco Company Information
  57. 8.10.2 Elanco Business Overview
  58. 8.10.3 Elanco Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Elanco Veterinary & Animal Vaccines Product Portfolio
  60. 8.10.5 Elanco Recent Developments
  61. 8.11 China Animal Husbandry
  62. 8.11.1 China Animal Husbandry Company Information
  63. 8.11.2 China Animal Husbandry Business Overview
  64. 8.11.3 China Animal Husbandry Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio
  66. 8.11.5 China Animal Husbandry Recent Developments
  67. 8.12 Boehringer Ingelheim
  68. 8.12.1 Boehringer Ingelheim Company Information
  69. 8.12.2 Boehringer Ingelheim Business Overview
  70. 8.12.3 Boehringer Ingelheim Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio
  72. 8.12.5 Boehringer Ingelheim Recent Developments
  73. 8.13 Biogenesis Bago
  74. 8.13.1 Biogenesis Bago Company Information
  75. 8.13.2 Biogenesis Bago Business Overview
  76. 8.13.3 Biogenesis Bago Veterinary & Animal Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio
  78. 8.13.5 Biogenesis Bago Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary & Animal Vaccines Value Chain Analysis
  2. 9.1.1 Veterinary & Animal Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary & Animal Vaccines Sales Mode & Process
  6. 9.2 Veterinary & Animal Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary & Animal Vaccines Distributors
  9. 9.2.3 Veterinary & Animal Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst